This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: **Inventor Profile: Jared C. Lewis**
Introduction
Jared C. Lewis is a notable inventor based in Oakland, California, recognized for his significant contributions to the field of pharmaceuticals. With one patent to his name, he has made advancements that could impact the treatment of eating disorders, weight gain, and obesity.
Latest Patents
Jared holds a patent for "2-Aminoquinolines as Melanin Concentrating Hormone Receptor Antagonists." This innovation relates to compounds that antagonize the effects of melanin-concentrating hormone (MCH) through its receptor, providing therapeutic potential for various metabolic disorders.
Career Highlights
Jared is currently associated with Abbott Laboratories Corporation, a leading global healthcare company committed to innovation. His work focuses on developing novel compounds that address critical health issues related to obesity and eating disorders.
Collaborations
Throughout his career, Jared has collaborated with esteemed colleagues, including Christine Ann Collins and Ju Gao. Together, they contribute to pioneering research that enhances the understanding and treatment of metabolic conditions.
Conclusion
Jared C. Lewis exemplifies the spirit of innovation within the pharmaceutical industry. His patented work on melanin concentrating hormone receptor antagonists underscores his commitment to improving health outcomes, particularly in addressing obesity and related disorders. As he continues his journey at Abbott Laboratories Corporation, his future endeavors are anticipated with great interest.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile